Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification

Table 9

Efficacy of different antifungal treatment strategies in high-, intermediate-, and low-risk groups.

Groups	Empirical therapy	Diagnostic-driven therapy	value
Group-1
Effective	80 (85.1%)	76 (85.4%)	0.956
Ineffective/death	14 (14.9%)	13 (14.6%)
Group-2
Effective	25 (80.6%)	22 (70.9%)	0.374
Ineffective/death	6 (19.4%)	9 (29.1%)
Group-3
Effective	18 (85.7%)	5 (41.6%)	0.008
Ineffective/death	3 (14.3%)	7 (58.4%)

Group-1: patients with one risk factor; group-2: patients with two risk factors; group-3: patients with more than three risk factors.